首页> 美国卫生研究院文献>Springer Open Choice >Development of an Analytical Method for the Rapid Quantitation of Peptides Used in Microbicide Formulations
【2h】

Development of an Analytical Method for the Rapid Quantitation of Peptides Used in Microbicide Formulations

机译:快速定量杀菌剂中使用的肽的分析方法的开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recently, a growing number of macromolecules such as peptides and proteins have been formulated into various microbicide formulations for the prevention of sexually transmitted infections. However, a fast and reliable high-throughput method for quantitating peptide/protein in polymer-based microbicide formulations is still lacking. As a result, we developed and validated a reversed-phase high-performance liquid chromatography method for the quantitation of gp120 fragment and LL-37 simultaneously in various microbicide gel formulations. This method was capable of detecting a limit of linearity (regression coefficient of 0.999) for gp120 fragment and LL-37 within a range of 0.625–80 and 1.25–80 µg mL−1, respectively. The lower limit of quantification for gp120 fragment and LL-37 was 1.14 and 0.31 µg mL−1, respectively. Method validation demonstrated acceptable intra- and inter-day RSD % (<5 %) and accuracy (95.67–100.5 %). Formulating both peptides into polymeric pharmaceutical gel formulations showed high extraction efficiency (in the range of 95.90 ± 3.03 to 111.45 ± 2.51 %). Using this method, we were able to separate and identify the forced degraded products from both peptides simultaneously without affecting the quantitation of both peptides in the polymeric dosage forms. Furthermore, this method was able to detect and separate degradants that were unable to be revealed using gel eletrophoresis.
机译:近来,已经将越来越多的大分子例如肽和蛋白质配制成各种杀微生物剂制剂,以防止性传播感染。然而,仍然缺乏用于定量基于聚合物的杀微生物剂制剂中的肽/蛋白质的快速且可靠的高通量方法。结果,我们开发并验证了一种反相高效液相色谱方法,用于同时定量各种杀菌剂凝胶制剂中的gp120片段和LL-37。此方法能够检测gp120片段和LL-37在0.625–80和1.25–80 µg mL -1 范围内的线性极限(回归系数为0.999)。 gp120片段和LL-37的定量下限分别为1.14和0.31 µg mL -1 。方法验证表明日内和日间RSD%(<5%)和准确度(95.67-100.5%)是可接受的。将两种肽配制成高分子药物凝胶制剂均显示出较高的提取效率(在95.90±3.03至111.45±2.51%的范围内)。使用这种方法,我们能够同时从两种肽中分离并鉴定出强制降解的产物,而不会影响聚合物剂型中两种肽的定量。此外,该方法能够检测并分离出使用凝胶电泳无法发现的降解物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号